Google
EVMN — EVOMMUNE, INC. (Healthcare >> Biotechnology)
EVMN FAQ
What is EVMN's ROE?
EVOMMUNE, INC. reports a Return on Equity (ROE) of -24.95%.
What is EVMN's dividend yield?
EVOMMUNE, INC. offers a dividend yield of 0.00%.
What is EVMN's Deepscope Quality Score?
Deepscope rates EVMN's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy EVMN?
Deepscope's AI Timing Score for EVMN is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does EVMN belong to?
EVOMMUNE, INC. is classified under the Healthcare >> Biotechnology sector on the NYSE exchange.
|
USD 20.49
Price
0.00
(0.00%)
Day Change
|
|
|---|
EVMN, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
41% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 90 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 20.49 |
| PBV / Sector |
2.36 / 4.71
|
| Earning Per Share | -2.17 |
| PE / Sector |
N/A / 17.58
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
8.53 M
|
| Average 1W Daily Value |
8.60 M
|
| Timing Factors |
|
28% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
64% |
| 配当 |
|
8% |
| 登録情報 |
| Analyze Date | 2026-06-10 09:43:33 |
| Symbol | EVMN |
| Name | EVOMMUNE, INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NYSE |
| Listed Shares | 36.02 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 717.49 / 8,889.42 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1841 Page Mill Road, Palo Alto, CA, United States, 94304
Phone: 925 247 4481
Website: https://www.evommune.com
Sector: Healthcare >> Biotechnology
Description: Evommune, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on chronic spontaneous urticaria, atopic dermatitis, and ulcerative colitis. Its products include EVO756 for the treatment of CSU and AD; and EVO301 for the treatment of AD and UC. The company was incorporated in 2020 and is based in Palo Alto, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
